Journal of Clinical Epidemiology

Journal of Clinical Epidemiology The Journal of Clinical Epidemiology promotes healthcare services research through the advancement and application of innovative methods.

We aim at promoting the quality of clinical and patient-oriented health services research through the advancement and application of innovative methods of:

conducting and presenting primary research;
synthesizing research results;
disseminating results;
and translating results into optimal clinical practice;
with special attention to the training of new generations of scientists and clinical practice leaders

The scoping review highlights the crucial need for standardized reporting of health equity in research studies. During t...
06/19/2023

The scoping review highlights the crucial need for standardized reporting of health equity in research studies.
During their investigation, the researchers identified 13 additional items that can significantly contribute to the understanding and reporting of health equity. These items cover various aspects, such as defining health equity terms, acknowledging the role of racism and discrimination, considering the composition and training of researchers, incorporating relevant factors in study methods, and facilitating data sharing across equity factors. This comprehensive approach aims to provide a holistic perspective on health equity.

To evaluate the support from the available guidance on reporting of health equity in research for our candidate items and to identify additional items for the STROBE (Strengthening Reporting of Observational studies in Epidemiology)-Equity extension.

Authors often rely on statistical significance alone and may  overlook meaningful differences in nonsignificant effect e...
06/13/2023

Authors often rely on statistical significance alone and may overlook meaningful differences in nonsignificant effect estimates

To assess the language used by systematic review authors to emphasize that statistically nonsignificant results show meaningful differences. To determine whether the magnitude of these treatment effects was distinct from nonsignificant results that authors interpreted as not different.

The Journal of Clinical Epidemiology is publishing a special issue on Methodological Considerations Related to Equity, D...
03/06/2023

The Journal of Clinical Epidemiology is publishing a special issue on Methodological Considerations Related to Equity, Diversion, and Inclusion (EDI) in Clinical Epidemiology. Articles in this special issue will discuss specific methods challenges and solutions related to EDI. All submissions must have a methodological focus. We welcome submissions addressing both quantitative and/or qualitative methods.

Read the latest articles of Journal of Clinical Epidemiology at ScienceDirect.com, Elsevier’s leading platform of peer-reviewed scholarly literature

https://www.jclinepi.com/article/S0895-4356(22)00304-3/fulltext
02/13/2023

https://www.jclinepi.com/article/S0895-4356(22)00304-3/fulltext

The commentary published by Dr Reed (ref) highlights challenges that decision-makers, including guideline developers, face when approaching evidence about diagnostic imaging tests. Specifically, the important challenges relate to when the reference standard for a test: 1. is not clearly defined or e...

https://www.jclinepi.com/article/S0895-4356(22)00344-4/fulltext
02/13/2023

https://www.jclinepi.com/article/S0895-4356(22)00344-4/fulltext

To introduce methods for living guidelines based in practical experiences by the Australian Living Evidence Consortium (ALEC), the National Institute of Health and Care Excellence (NICE) and the Infectious Diseases Society of America (IDSA), with methodological support from the United States (US) Gr...

https://www.jclinepi.com/article/S0895-4356(23)00032-X/fulltextCEAs sponsored by the industry were more likely to report...
02/13/2023

https://www.jclinepi.com/article/S0895-4356(23)00032-X/fulltext

CEAs sponsored by the industry were more likely to report ICERs below $50,000/QALY (adjusted odds ratio (OR), 1.91, 95% confidence interval (CI), 1.45-2.51, p

Cost effectiveness analysis (CEA) has been increasingly used to inform cancer treatment coverage policy making worldwide. The primary objective of this study was to assess the association between industry sponsorship and CEA results in oncology.

Address

Ottawa, ON
K1N6N5

Alerts

Be the first to know and let us send you an email when Journal of Clinical Epidemiology posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Share

Share on Facebook Share on Twitter Share on LinkedIn
Share on Pinterest Share on Reddit Share via Email
Share on WhatsApp Share on Instagram Share on Telegram